ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.420
+0.050 (3.65%)
At close: Dec 5, 2025, 4:00 PM EST
1.430
+0.010 (0.70%)
After-hours: Dec 5, 2025, 7:49 PM EST
ALX Oncology Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -108.01 | -134.85 | -160.81 | -123.48 | -83.46 | -45.74 | |
| Depreciation & Amortization | 0.77 | 0.87 | 0.84 | 0.34 | 0.05 | 0.2 | |
| Other Amortization | 0.28 | 0.27 | 0.25 | 0.04 | - | 0.42 | |
| Loss (Gain) From Sale of Assets | - | 0.01 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -1.79 | -4.66 | -6.49 | -0.94 | - | - | |
| Stock-Based Compensation | 15.73 | 27.09 | 26.27 | 23.84 | 13.91 | 5.44 | |
| Other Operating Activities | 1.81 | 1.79 | 1.27 | 1.12 | 5.42 | 1.15 | |
| Change in Accounts Receivable | - | - | - | - | - | 0.54 | |
| Change in Accounts Payable | -1.3 | -4.02 | 0.46 | 4.51 | 3.29 | -3.74 | |
| Change in Other Net Operating Assets | -7.87 | -8.41 | 7.84 | 5.34 | -7.32 | 3.46 | |
| Operating Cash Flow | -97.21 | -121.91 | -130.36 | -89.22 | -68.1 | -38.29 | |
| Capital Expenditures | -0.22 | -0.45 | -1.27 | -1.43 | -0.67 | -0.03 | |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.64 | |
| Sale (Purchase) of Intangibles | - | - | - | - | -4.26 | - | |
| Investment in Securities | 104.76 | 86.7 | 45.93 | -233.99 | - | - | |
| Investing Cash Flow | 104.54 | 86.26 | 44.66 | -235.42 | -4.92 | 0.61 | |
| Long-Term Debt Issued | - | - | - | 10 | - | - | |
| Long-Term Debt Repaid | - | -0.83 | -0.39 | -0.39 | -0.28 | -6.51 | |
| Net Debt Issued (Repaid) | -0.78 | -0.83 | -0.39 | 9.61 | -0.28 | -6.51 | |
| Issuance of Common Stock | 0.06 | 1.98 | 64.08 | 0.9 | 2.75 | 368.56 | |
| Other Financing Activities | 0.73 | 29.66 | -4.4 | -0.66 | - | -3.85 | |
| Financing Cash Flow | 0.01 | 30.82 | 59.29 | 9.86 | 2.47 | 462.88 | |
| Net Cash Flow | 7.34 | -4.84 | -26.42 | -314.78 | -70.55 | 425.2 | |
| Free Cash Flow | -97.43 | -122.36 | -131.64 | -90.65 | -68.77 | -38.32 | |
| Free Cash Flow Margin | - | - | - | - | - | -3241.96% | |
| Free Cash Flow Per Share | -1.82 | -2.35 | -3.06 | -2.23 | -1.71 | -2.07 | |
| Cash Interest Paid | 1.39 | 1.39 | 1.18 | 0.1 | 0.01 | 0.43 | |
| Cash Income Tax Paid | - | - | - | - | 0.27 | 0.05 | |
| Levered Free Cash Flow | -59.85 | -82.86 | -74.8 | -44.64 | -36.42 | -21.02 | |
| Unlevered Free Cash Flow | -59.1 | -82.04 | -74.07 | -44.53 | -36.41 | -21.44 | |
| Change in Working Capital | -9.16 | -12.43 | 8.3 | 9.85 | -4.03 | 0.25 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.